These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 38506249)

  • 21. A prediction model for bacteremia and transfer to intensive care in pediatric and adolescent cancer patients with febrile neutropenia.
    Alali M; Mayampurath A; Dai Y; Bartlett AH
    Sci Rep; 2022 May; 12(1):7429. PubMed ID: 35523855
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Survey of practices for the clinical management of febrile neutropenia in children in hematology-oncology units in Latin America.
    Melgar MA; Homsi MR; Happ B; Su Y; Tang L; Gonzalez ML; Caniza MA
    Support Care Cancer; 2021 Dec; 29(12):7903-7911. PubMed ID: 34189607
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Early discharge of pediatric patients with cancer, fever, and neutropenia with low-risk of systemic infection.
    Gil-Veloz M; Pacheco-Rosas DO; Solórzano-Santos F; Villasís-Keever MA; Betanzos-Cabrera Y; Miranda-Novales G
    Bol Med Hosp Infant Mex; 2018; 75(6):352-357. PubMed ID: 30407457
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Plasma presepsin level is an early diagnostic marker of severe febrile neutropenia in hematologic malignancy patients.
    Koizumi Y; Shimizu K; Shigeta M; Okuno T; Minamiguchi H; Kito K; Hodohara K; Yamagishi Y; Andoh A; Fujiyama Y; Mikamo H
    BMC Infect Dis; 2017 Jan; 17(1):27. PubMed ID: 28056845
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Febrile neutropenia risk assessment tool: improving clinical outcomes for oncology patients.
    O'Brien C; Dempsey O; Kennedy MJ
    Eur J Oncol Nurs; 2014 Apr; 18(2):167-74. PubMed ID: 24290035
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Characterization of episodes of febrile neutropenia in children with acute myeloid leukemia and acute lymphoblastic leukemia].
    Ducasse K; Fernández JP; Salgado C; Alvarez AM; Avilés CL; Becker A; Topelberg S; Tordecilla J; Varas M; Villarroel M; Viviani T; Zubieta M; Santolaya ME
    Rev Chilena Infectol; 2014 Jun; 31(3):333-8. PubMed ID: 25146209
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Evaluation of Possible Effects of the COVID-19 Pandemic on Febrile Neutropenia Episodes in Children With Acute Leukemia.
    Erbaş İC; Tüfekçi Ö; Akyol Ş; Asrak HK; Güzin AÇ; Alataş ŞÖ; Yilmaz Ş; Ören H; Belet N
    J Pediatr Hematol Oncol; 2022 Oct; 44(7):e976-e981. PubMed ID: 34654763
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Absolute Monocyte Count as Early and Safe Marker for Antibiotic Cessation in Febrile Neutropenia Without Etiology in Pediatric Oncology Patients.
    Alali M; Prather C; Danziger-Isakov LA; Kussin ML; Khalifeh M; Al Othman N; Bartlett AH
    J Pediatr Hematol Oncol; 2023 Aug; 45(6):e702-e709. PubMed ID: 37494607
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Clinical practice guideline-inconsistent management of fever and neutropenia in pediatric oncology: A Children's Oncology Group study.
    Dupuis LL; Fisher BT; Sugalski AJ; Grimes AC; Nuño M; Ramakrishnan S; Beauchemin MP; Robinson PD; Santesso N; Walsh A; Wrightson AR; Yu L; Parsons SK; Sung L
    Pediatr Blood Cancer; 2024 Apr; 71(4):e30880. PubMed ID: 38291716
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Management of febrile neutropenia in solid tumours and lymphomas using the Multinational Association for Supportive Care in Cancer (MASCC) risk index: feasibility and safety in routine clinical practice.
    Innes H; Lim SL; Hall A; Chan SY; Bhalla N; Marshall E
    Support Care Cancer; 2008 May; 16(5):485-91. PubMed ID: 17899215
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A prospective study of febrile neutropenia in pediatric cancer patients in Jordan.
    Al Omar S; Nazer L; Alkayed K
    J Pediatr Hematol Oncol; 2013 Nov; 35(8):614-7. PubMed ID: 23823118
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Evaluating the accuracy and efficacy of an electronic medical record alert to identify paediatric patients with low-risk febrile neutropenia.
    Corrente C; Satkumaran S; Segal A; Butters C; Fernandez C; Babl FE; Orme LM; Thursky K; Haeusler GM
    Int J Med Inform; 2023 Oct; 178():105205. PubMed ID: 37703799
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Direct costs associated with febrile neutropenia in inpatients with hematological diseases in Singapore.
    Zhou YP; Jin J; Ding Y; Chee YL; Koh LP; Chng WJ; Chan DS; Hsu LY
    Support Care Cancer; 2014 Jun; 22(6):1447-51. PubMed ID: 24287505
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Emergency department management of chemotherapy related febrile neutropenia: An opportunity to improve care.
    Pettit N; Boadu D; Bischof JJ
    Am J Emerg Med; 2021 Dec; 50():5-9. PubMed ID: 34265732
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Development of pediatric oncology supportive care indicators: Evaluation of febrile neutropenia care in the north of the Netherlands.
    Ten Berg S; Loeffen EAH; van de Wetering MD; Martens DHJ; van Ede CM; Kremer LCM; Tissing WJE
    Pediatr Blood Cancer; 2019 Feb; 66(2):e27504. PubMed ID: 30318786
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Emergency Department Management of Patients With Febrile Neutropenia: Guideline Concordant or Overly Aggressive?
    Baugh CW; Wang TJ; Caterino JM; Baker ON; Brooks GA; Reust AC; Pallin DJ
    Acad Emerg Med; 2017 Jan; 24(1):83-91. PubMed ID: 27611638
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Febrile neutropenia in adjuvant and neoadjuvant chemotherapy for breast cancer: a retrospective study in routine clinical practice from a single institution.
    Bacrie J; Laurans M; Iorio P; Fourme E; Volters AB; Bozec L; Lerebours F; Dubot C; Bensaoula O; Benzidane B; Pierga JY; Lefeuvre D
    Support Care Cancer; 2018 Dec; 26(12):4097-4103. PubMed ID: 29855772
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Predictive Factors of Severe Adverse Events in Pediatric Oncologic Patients with Febrile Neutropenia.
    Thangthong J; Anugulruengkitt S; Lauhasurayotin S; Chiengthong K; Poparn H; Sosothikul D; Techavichit P
    Asian Pac J Cancer Prev; 2020 Dec; 21(12):3487-3492. PubMed ID: 33369443
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Simple predictors of the re- occurrence of severe febrile neutropenia episode: a single-center retrospective cohort study in pediatric patients with malignant diseases.
    Šegulja S; Ružić A; Dujmić D; Baždarić K; Roganović J
    Croat Med J; 2019 Feb; 60(1):20-25. PubMed ID: 30825274
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Meta-ethnography of experiences of early discharge, with a focus on paediatric febrile neutropenia.
    Morgan JE; Cleminson J; Stewart LA; Phillips RS; Atkin K
    Support Care Cancer; 2018 Apr; 26(4):1039-1050. PubMed ID: 29285558
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.